Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung Cancer

NCT03515252 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

NSCLC Stage IIIB
NSCLC Stage IV
Hepatocellular Carcinoma by BCLC Stage
Lung Cancer
Liver Cancer

Interventions

BIOLOGICAL: Immune Killer Cells (IKC)

Sponsor

Ivy Life Sciences, Co., Ltd